Eminence Capital, LP Haemonetics Corp Transaction History

Eminence Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$84.96 - $118.91 $72 Million - $101 Million	-847,328 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $41.4 Million - $67.9 Million	557,188 Added 192.04%	847,328 $84.4 Million
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $979,693 - $1.11 Million	-8,566 Reduced 2.87%	290,140 $33.3 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $68.1 Million - $80.6 Million	-581,513 Reduced 66.06%	298,706 $37.7 Million
Q2 2019 Aug 14, 2019	BUY	$81.74 - $120.34 $62.8 Million - $92.5 Million	768,863 Added 690.45%	880,219 $106 Million
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $9.27 Million - $11.4 Million	111,356 New	111,356 $9.74 Million

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.